Lieberman, D., Abbott, D. H., O’Leary, M. C., Hauser, E. R., Williams, C., McNeil, R. B., … Provenzale, D. (2016). 858 Clinical Risk Group at Baseline Is Associated With 10 Year Outcomes in a Screening Cohort-Longitudinal Analysis of the CSP 380 Cohort. In Gastroenterology (Vol. 150, pp. S184–S184). Elsevier BV. https://doi.org/10.1016/s0016-5085(16)30701-6

Lieberman, David, David H. Abbott, Meghan C. O’Leary, Elizabeth R. Hauser, Christina Williams, Rebecca B. McNeil, Brian Sullivan, et al. “858 Clinical Risk Group at Baseline Is Associated With 10 Year Outcomes in a Screening Cohort-Longitudinal Analysis of the CSP 380 Cohort.” In Gastroenterology, 150:S184–S184. Elsevier BV, 2016. https://doi.org/10.1016/s0016-5085(16)30701-6.

Lieberman D, Abbott DH, O’Leary MC, Hauser ER, Williams C, McNeil RB, et al. 858 Clinical Risk Group at Baseline Is Associated With 10 Year Outcomes in a Screening Cohort-Longitudinal Analysis of the CSP 380 Cohort. In: Gastroenterology. Elsevier BV; 2016. p. S184–S184.

Lieberman, David, et al. “858 Clinical Risk Group at Baseline Is Associated With 10 Year Outcomes in a Screening Cohort-Longitudinal Analysis of the CSP 380 Cohort.” Gastroenterology, vol. 150, no. 4, Elsevier BV, 2016, pp. S184–S184. Crossref, doi:10.1016/s0016-5085(16)30701-6.

Lieberman D, Abbott DH, O’Leary MC, Hauser ER, Williams C, McNeil RB, Sullivan B, Musselwhite L, Gellad ZF, Weiss D, Provenzale D. 858 Clinical Risk Group at Baseline Is Associated With 10 Year Outcomes in a Screening Cohort-Longitudinal Analysis of the CSP 380 Cohort. Gastroenterology. Elsevier BV; 2016. p. S184–S184.